Furthermore, overexpression of miR-93, miR-216a, or miR-223 expression in ovarian cancer can result in increased cisplatin resistance due to activation of the PI3K/AKT pathway, which is mediated by sponging off the PTEN transcription factor [80, 87, 88, 102, 103]. This evidence concerns the gene AKT1 and ovarian carcinoma.